247 related articles for article (PubMed ID: 17898269)
61. Expression of neurotrophic factors in human primary pterygeal tissue and selective TNF-alpha-induced stimulation of ciliary neurotrophic factor in pterygeal fibroblasts.
Hong S; Choi JY; Lee HK; Seong GJ; Seo KY; Kim EK; Byeon SH
Exp Toxicol Pathol; 2008 Sep; 60(6):513-20. PubMed ID: 18585018
[TBL] [Abstract][Full Text] [Related]
62. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
63. [Expression of matrix metalloproteinase in human pterygia].
Zeng J; Jiang D; Liu X; Tang L
Yan Ke Xue Bao; 2004 Dec; 20(4):242-5. PubMed ID: 15656370
[TBL] [Abstract][Full Text] [Related]
64. Expression of p63 and p16 in primary and recurrent pterygia.
Ramalho FS; Maestri C; Ramalho LN; Ribeiro-Silva A; Romão E
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1310-4. PubMed ID: 16523297
[TBL] [Abstract][Full Text] [Related]
65. Pathogenesis of pterygium.
Hill JC; Maske R
Eye (Lond); 1989; 3 ( Pt 2)():218-26. PubMed ID: 2695353
[TBL] [Abstract][Full Text] [Related]
66. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
67. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M; Boczek-Leszczyk E
J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
[TBL] [Abstract][Full Text] [Related]
68. Paracrine-like excitation of low-threshold mechanoceptive C-fibers innervating rat hairy skin is mediated by substance P via NK-1 receptors.
Zhang SH; Sun QX; Seltzer Z; Cao DY; Wang HS; Chen Z; Zhao Y
Brain Res Bull; 2008 Jan; 75(1):138-45. PubMed ID: 18158108
[TBL] [Abstract][Full Text] [Related]
69. Effects of substance P microinjections into the globus pallidus and central nucleus of amygdala on passive avoidance learning in rats.
Kertes E; László K; Berta B; Lénárd L
Behav Brain Res; 2009 Mar; 198(2):397-403. PubMed ID: 19071162
[TBL] [Abstract][Full Text] [Related]
70. The presence of T-lymphocyte subpopulations (CD4 and CD8) in pterygia: evaluation of the inflammatory response.
Awdeh RM; DeStafeno JJ; Blackmon DM; Cummings TJ; Kim T
Adv Ther; 2008 May; 25(5):479-87. PubMed ID: 18483701
[TBL] [Abstract][Full Text] [Related]
71. Herpes simplex virus and pterygium in Taiwan.
Chen YF; Hsiao CH; Ngan KW; Yeung L; Tan HY; Yang KH; Huang SC; Lin KK
Cornea; 2008 Apr; 27(3):311-3. PubMed ID: 18362659
[TBL] [Abstract][Full Text] [Related]
72. Induction of endothelial RAGE expression in pterygium.
Al-Swailem S; Xu Z; Wu L; Hartsock MJ; Yiu SC; Duh EJ
Mol Vis; 2014; 20():1740-8. PubMed ID: 25593504
[TBL] [Abstract][Full Text] [Related]
73. Impression cytology of pterygium.
Wang IJ; Lai WT; Liou SW; Chiu CZ; Hu FR; Kao WW; Hung PT
J Ocul Pharmacol Ther; 2000 Dec; 16(6):519-28. PubMed ID: 11132899
[TBL] [Abstract][Full Text] [Related]
74. Substance P expression by human dental pulp fibroblasts: a potential role in neurogenic inflammation.
Killough SA; Lundy FT; Irwin CR
J Endod; 2009 Jan; 35(1):73-7. PubMed ID: 19084129
[TBL] [Abstract][Full Text] [Related]
75. Cyclooxygenase-2 expression in primary and recurrent pterygium.
Karahan N; Baspinar S; Ciris M; Baydar CL; Kapucuoglu N
Indian J Ophthalmol; 2008; 56(4):279-83. PubMed ID: 18579985
[TBL] [Abstract][Full Text] [Related]
76. A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage.
Esteban F; Muñoz M; González-Moles MA; Rosso M
Cancer Metastasis Rev; 2006 Mar; 25(1):137-45. PubMed ID: 16680578
[TBL] [Abstract][Full Text] [Related]
77. [Fibroblasts from primary and recurrent pterygia and Tenon's capsule in cell culture].
Viveiros MM; Schellini SA; Rogato S; Rainho C; Padovani CR
Arq Bras Oftalmol; 2006; 69(1):57-62. PubMed ID: 16491236
[TBL] [Abstract][Full Text] [Related]
78. [The abnormal expression of interleukine-1 family in pterygium].
Wen Z; Liu Z
Yan Ke Xue Bao; 2003 Jun; 19(2):133-6. PubMed ID: 12870354
[TBL] [Abstract][Full Text] [Related]
79. Expression of vascular endothelial growth factor (VEGF) in macrophages, fibroblasts, and endothelial cells in pterygium treated with 5-Fluorouracil.
Hoyama E; Viveiros MM; Shiratori C; de Oliveira DE; Padovani CR; Selva D; Schellini SA
Semin Ophthalmol; 2015 May; 30(3):171-6. PubMed ID: 24171833
[TBL] [Abstract][Full Text] [Related]
80. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
